| Date | Title | Description |
| 06.01.2026 | The Standard of Care Shift: Heartflow Secures Nationwide Aetna Coverage for AI Plaque Analysis | What You Should Know
– Heartflow has achieved a major milestone as Aetna updates its policies to cover AI-driven Heartflow Plaque Analysis across all lines of business, effective December 23, 2025.
– This move, combined with the new Categor... |
| 10.11.2025 | Section Partners: $189 Million Raised For Two New Funds | Section Partners announced the final closing of two investment vehicles totaling $189 million in capital commitments, reflecting continued backing from existing investors and interest from new limited partners. The capital was raised across... |
| 22.09.2025 | Heartflow Receives FDA Clearance for Next-Gen AI Plaque Analysis, Expands Cigna Coverage | What You Should Know:
– Heartflow, a leader in AI technology for coronary artery disease (CAD), has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Next Gen Heartflow Plaque Analysis algorithm and platform.
– The t... |
| 05.09.2025 | Ketryx Secures $39M: AI Revolutionizes Medtech Compliance and Speed | Ketryx secured $39M in Series B funding. This investment pushes total funding past $55M. Transformation Capital led the round. Lightspeed Venture Partners, MIT’s E14 Fund, Ubiquity Ventures, and 53 Stations also participated. This capital i... |
| 05.09.2025 | Ketryx: $39 Million Series B Raised For Advancing AI-Based Compliance in Life Sciences | Ketryx, a rapidly growing AI-based compliance platform built for the life sciences industry, has announced the close of its $39 million Series B funding round. Led by Transformation Capital, the round also saw continued support from existin... |
| 04.09.2025 | Ketryx raises $39M to help medical device makers ship safer products faster
Send us a News Tip
EXTRACT THE SIGNAL FROM THE NOISE
Cookies | Ketryx Corp., a company transforming product lifecycle development and compliance for medical device makers with artificial intelligence, today announced it has raised $39 million in a Series B funding round led by Transformation Capital.
T... |
| 04.09.2025 | Ketryx raises $39M to advance AI compliance in life sciences | Austrian-American Ketryx, the AI-powered compliance platform helping life sciences companies ship safer products faster, today announced a $39 million Series B, bringing the company’s total funding to over $55 million.
Life sciences teams f... |
| 04.09.2025 | Ketryx Raises $39M to Accelerate AI-Powered Compliance in Life Sciences | What You Should Know:
– Ketryx, the AI-powered compliance platform helping life sciences companies ship safer products faster, today announced a $39 million Series B led by Transformation Capital, with participation from existing investors ... |
| 04.09.2025 | Ketryx Raises $39M in Series B Funding | Ketryx, a Cambridge, MA-based AI-powered compliance platform helping life sciences companies ship safer products faster, raised $39M in Series B funding.
The round was led by Transformation Capital, with participation from existing investor... |
| 11.08.2025 | Heartflow оценили в $1,54 млрд после IPO для развития ИИ-сервиса диагностики сердца | Компания из Маунтин-Вью (Калифорния) продала 16,67 млн акций по $19 за штуку, тогда как целевой диапазон составлял $17–18. Ранее на этой неделе Heartflow увеличила объем размещения и повысила ценовой диапазон на фоне высокого спроса. IPO оц... |
| 11.08.2025 | Heartflow Raises $316.7 Million in IPO at a $2.27 Billion Valuation
Only paid subscribers can comment on this post | Heartflow is a medtech company revolutionizing cardiovascular care with its AI-powered, non-invasive heart imaging technology. The platform creates personalized 3D models of a patient’s coronary arteries from CT scans, enabling clinicians t... |
| 08.08.2025 | Bain Capital-backed Heartflow valued at $2.27 billion in solid Nasdaq debut | Bain Capital-backed Heartflow valued at $2.27 billion in solid Nasdaq debut
By Rishab Shaju and Ateev BhandariAugust 8, 20256:11 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
The Nasdaq logo i... |
| 23.06.2025 | The Battle for Sustainable Packaging: Boxed Water Faces Scrutiny | In a world increasingly aware of environmental issues, the packaging industry stands at a crossroads. The rise of sustainable alternatives has sparked a fierce competition among brands. One player, Boxed Water is Better, has recently found ... |
| 20.06.2025 | AI-Driven Diagnostics: The Future of Precision in Medical Imaging | Thomas Kluz, Managing Director at Niterra Venture
During the past ten years, I’ve collaborated and invested in several innovative healthcare organizations, and I have realized that AI has extended beyond just being a supporting tool for med... |
| 27.03.2025 | Heartflow Secures $98 Million to Revolutionize Coronary Care | In a significant move for the healthcare technology sector, Heartflow, Inc. has announced a successful financing round, securing approximately $98 million through the issuance of convertible notes. This funding comes from a mix of new and e... |
| 27.03.2025 | Heartflow Completes $98M Convertible Notes Financing | Heartflow, Inc., a Mountain View, CA-based leader in AI technology for coronary artery disease (CAD), received additional investments of approximately $98m through the sale and issuance of convertible notes by its parent company, Heartflow ... |
| 26.03.2025 | Heartflow Closes $98 Million Convertible Notes Financing | Additional Capital to Support Broadening Adoption of a Leading Platform That Transforms Diagnosis and Management of Coronary Artery Disease
MOUNTAIN VIEW, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc., the leader in AI technolo... |
| 26.03.2025 | Heartflow Closes $98 Million Convertible Notes Financing | - |
| 26.03.2025 | Heartflow Closes $98 Million Convertible Notes Financing | MOUNTAIN VIEW, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc., the leader in AI technology for coronary artery disease (CAD), today announced additional investments in the company of approximately $98 million through the sale an... |
| 05.03.2025 | Learn More about the Heartflow's Story | - |
| 06.12.2024 | Cleerly scores $106M for heart disease diagnosis tools | Photo: REB Images/Getty Images
Cardiovascular imaging company Cleerly announced it raised $106 million in a Series C funding round.
The round was led by Insight Partners and Battery Ventures with participation from pre-existing investors.
W... |
| 03.06.2024 | HeartFlow AI Plaque Analysis Achieves Major Milestone Towards Medicare Coverage | - |
| 12.03.2024 | HeartFlow Announces Publication of 10-year Follow-Up Data from the DISCOVER-FLOW Study in the Journal of Cardiovascular Computed Tomography | - |
| 08.03.2024 | Healthcare Digital Twin Market Size to Worth USD 38.43 Bn by 2032 | The global healthcare digital twin market size surpassed USD 1.61 billion in 2023 and is expected to be worth around USD 38.43 billion by 2032, a study published by Towards Healthcare a sister firm of Precedence Research.
Ottawa, March 08, ... |
| 10.04.2023 | HeartFlow Closes $215M Series F Funding |
MOUNTAIN VIEW, CA, HeartFlow announced the close of a $215M Series F funding round.
>> Click here for more funding data on HeartFlow
>> To export HeartFlow funding data to PDF and Excel, click here
HeartFlow, the leader i... |
| 06.04.2023 | HeartFlow, Leader in Revolutionizing Precision Heart Care, Closes $215 Million in Series F Funding Led by Bain Capital Life Sciences | - |
| 06.04.2023 | HeartFlow Closes $215M in Series F Funding | HeartFlow, a Mountain View, CA-based precision heart care company, raised $215M in Series F funding.
The round was led by Bain Capital Life Sciences with participation from new investor, Janus Henderson Investors, and existing investors, in... |
| 06.04.2023 | HeartFlow, Leader in Revolutionizing Precision Heart Care, Closes $215 Million in Series F Funding Led by Bain Capital Life Sciences | Financing will further drive commercial scale for HeartFlow’s AI-enabled portfolio of precision heart care products
/EIN News/ -- MOUNTAIN VIEW, Calif., April 06, 2023 (GLOBE NEWSWIRE) -- HeartFlow, Inc., the leader in revolutionizing preci... |
| 06.04.2023 | HeartFlow, Leader in Revolutionizing Precision Heart Care, Closes $215 Million in Series F Funding Led by Bain Capital Life Sciences | - |
| 05.04.2023 | Sorin Medical Receives the Heartflow CT Quality Award for 4th Quarter of 2022 | Sorin Medical Team Receiving HeartFlow CT Quality Award
NEW YORK CITY, NEW YORK, USA, April 5, 2023/EINPresswire.com/ -- SORIN MEDICAL (https://sorinmedicalny.com/) is proud to announce they have received the HeartFlow CT (https://www.heart... |
| 15.07.2021 | LONGVIEW ACQUISITION CORP. II : Other Events, Financial Statements and Exhibits (form 8-K) | Item 8.01. Other Events.
On July 15, 2021, Longview Acquisition Corp. II ("Longview" or the "Company") announced a proposed business combination (the "Business Combination") between Longview and HeartFlow Holdi... |
| 13.02.2020 | These are the startups on the front lines of the medical imaging space | The amount of funding invested into the space more than doubled in 2018
Misdiagnosis is a major problem in healthcare: not only are 12 million Americans misdiagnosed each year, nearly a third of these cases result in serious injury, or even... |
| 14.08.2019 | Can Highmark successfully commercialize the healthcare innovation process? | Pittsburgh-based integrated health system Highmark Health created its VITAL Innovation Program in 2015 to use the organization’s resources as a way to test FDA-approved technologies internally.
VITAL is organized under the overarching Highm... |
| 05.12.2018 | «Занимаешься всем подряд — не построишь продукт, где нужно много экспертизы». CTO стартапа, куда вложились основатели MSQRD, говорит про «зубной» AI с планом на миллиард... | Нина Шулякова Медтех 5 декабря 2018, 08:30 «Занимаешься всем подряд — не построишь продукт, где нужно много экспертизы». CTO стартапа, куда вложились основатели MSQRD, говорит про «зубной» AI с планом на миллиард
Оставить комментарий... |
| 14.11.2018 | Exclusive: Digital health company HeartFlow gets Japanese reimbursement approval for cardiac diagnostic tech | The company claims that using its technology allows doctors to make more cost-efficient and safer clinical care decisions for people with suspected coronary artery disease (CAD) by avoiding the risk factors like bleeding, bruising and infec... |
| 05.06.2018 | Genetesis noninvasive heart disease detection device attracts reinvestment from Mark Cuban’s firm in Series A | In an interview last year, Genetesis CEO and Co-founder Peeyush Shrivastava said the company’s technology is designed to address a significant public health burden.
“Where our technology fits in is we have a really high negative predictive ... |
| 22.05.2018 | HeartFlow’s AI coronary test outperforms conventional alternatives | Coronary artery disease is notoriously tricky to diagnose, which is one of the reasons it accounts for 801,000 deaths per year in the U.S. alone, according to the American Heart Association. (That’s more than all forms of cancer and Chronic... |
| 22.05.2018 | HeartFlow’s AI coronary test outperforms conventional alternatives | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
Coronary artery disease is notoriously tricky to ... |
| 02.04.2018 | Rock Health: Record Q1 brings in $1.6B for digital health investments, disease diagnosis segment dominates (Updated) | Consistent with previous reports on digital health — the average investment size per deal continued to climb. In the first quarter, average deal size rose to $21 million compared with $16.4 million last year. The 10 largest deals accounted ... |
| 15.02.2018 | DroneBase Raises $12M For Commercial Drone Ops | 11 Shares Email Facebook Twitter LinkedIn
Morning Report: DroneBase picks up $12 million more from USV, Upfront Ventures, Hearst Ventures, Pritzker Group, and DJI.
DroneBase announced a fresh $12 million Series B, following its mid-2016, $6... |
| 15.02.2018 | Term Sheet — Thursday, February 15 | SO LONG, SAN FRANCISCO
Good morning, Term Sheet readers.
Paid Content Securing the enterprise without boundaries From ExtraHop
Mr. Thiel has long stood out in Silicon Valley for his vocal libertarianism, but he drew heavy criticism from man... |
| 14.02.2018 | HeartFlow Completes $240M Series E Financing |
REDWOOD CITY, CA, HeartFlow, Inc. today announced the closing of its Series E financing, securing $240 million.
>> Click here for more funding data on HeartFlow
>> To export HeartFlow funding data to PDF and Excel, click her... |
| 14.02.2018 | HeartFlow Completes Series E Financing, Securing $240 Million | - |
| 14.02.2018 | HeartFlow Raises $240M Series E from Wellington Management | REDWOOD CITY, Calif.--(BUSINESS WIRE)--HeartFlow, Inc. today announced the closing of its Series E financing, securing $240 million. The company will use the proceeds from this financing to ramp up commercial expansion of the HeartFlow®FFRc... |
| 14.02.2018 | HeartFlow Completes $240M Series E Financing | HeartFlow, Inc., a Redwood City, Calif.-based medical technology company focused on heart disease, closed its $240m Series E financing.
Backers included Wellington Management, Baillie Gifford & Company and existing investors.
The compan... |
| 03.11.2016 | The top 15 healthcare deals of 2016 | There has been $13.1 billion invested across 1,287 deals so far this year
Even as venture funding has slowed down this year, healthcare has remained one of the top spaces for companies to raise money.
In the first quarter of this year, even... |
| 12.02.2015 | Heartflow just raised $35.8M for 3D modeling of arteries… so when’s it gonna IPO? | Heartflow’s noninvasive diagnostic tool lets doctors get a 3D view of a patient’s bloodflow and arterial structure. For instance, the software can identify different coronary lesions that cause arterial blockage, and pinpoint other signs of... |
| 02.12.2014 | HeartFlow wins FDA OK for non-invasive FFR system | By Brad Perriello and Mark Hollmer
HeartFlow yesterday said it won de novo clearance from the FDA for its non-invasive cloud-based cardiac imaging technology, which CEO Dr. John Stevens told MassDevice.com is the "most spectacular"... |
| 29.04.2014 | Digital health investment tops $1.35 billion in first quarter | The largest deals of the first quarter give some clues on some areas of interest, and help give a sense of investment priorities:
Heart Flow raised $105 million. It’s a noninvasive diagnosis of coronary artery disease. It gives medical prof... |
| 09.01.2013 | Cardiology-focused startup improving FFR emerges in Cleveland with $250K investment | Pollman declined to go into too much detail about the specifics behind the guide wire that his new startup is developing, saying only that it takes advantage of technological advances in other industries.
“The challenge with current product... |
| 09.05.2012 | 5 cardiovascular disease medical device companies to watch | “The aging of the population and the near epidemic of obesity and type 2 diabetes even in the younger population will prolong this trend and sustain potential in this market for a long time to come,” said Kenneth Krul, author of a cardiovas... |
| 14.02.2012 | Noninvasive diagnostic test to guide heart disease treatment secures $75M | Cardiovascular imaging and diagnostics represents a huge global market opportunity, but there is also lots of competition in other techniques that evaluate narrowed coronary arteries, including coronary angiography, intravascular ultrasound... |
| - | Cardiology-focused startup improving FFR emerges in Cleveland with $250K investment | A new Cleveland-based startup is innovating on diagnostic technology in cardiology with the hope of getting into a $1 billion (and growing) market dominated by St. Jude Medical and Volcano Corp.
Fractional flow reserve, or FFR, is a techniq... |
| - | Genetesis noninvasive heart disease detection device attracts reinvestment from Mark Cuban’s firm in Series A | Genetesis, a Cincinnati-based clinical decision support business that developed a 3D mapping tool to help clinicians spot underlying cardiac disorders earlier, has closed a $7.5 million Series A round, according to a news release. The new f... |
| - | Precision Heart Care Company HeartFlow Raises $215 Million | HeartFlow – a leader in precision heart care – announced it has closed $215 million in Series F funding led by Bain Capital Life Sciences with participation from new investor, Janus Henderson Investors, and existing investors, including Bai... |
| - | Can Highmark successfully commercialize the healthcare innovation process? | Even if healthcare technology startups survive the venture capital valley of death, what may finish them off later is commercialization and the hurdles presented by reimbursement and slow adoption.
One purchaser of health tech has devised a... |
| - | Exclusive: Digital health company HeartFlow gets Japanese reimbursement approval for cardiac diagnostic tech | Redwood City, California-based digital health company HeartFlow has reached a major milestone in its international expansion efforts after Japan’s health ministry approved the reimbursement of its technology to analyze arterial blood flow.
... |
| - | Rock Health: Record Q1 brings in $1.6B for digital health investments, disease diagnosis segment dominates (Updated) | Note: This post has been updated with comments from Megan Zweig, Rock Health Director of Research.
Investment in digital health rose to its highest level for the first quarter of the year at $1.6 billion compared with $909 million for the s... |
| - | Digital health investment tops $1.35 billion in first quarter | StartUp Health Insights – Q1 2014 Update from StartUp Health
Last year investments in big data dominated health IT deals as 112 deals attracted $712 million in investments, according to a new report by StartUp Health assessing digital healt... |
| - | Heartflow just raised $35.8M for 3D modeling of arteries… so when’s it gonna IPO? | Medical software developer Heartflow just raised another hefty swath of cash. Isn’t it time the Bay area startup IPO’d?
Heartflow’s diagnostic software reconfigures medical imaging data, particularly from CT scans, to build 3D models of pat... |
| - | HeartFlow | “Bringing together human ingenuity and advanced AI technology to help combat the #1 cause of death.” |
| - | Noninvasive diagnostic test to guide heart disease treatment secures $75M | A cardiovascular diagnostic company hoping to redefine the standard for how heart disease is diagnosed has secured nearly $75 million for its noninvasive fractional flow reserve/computed tomography test.
Whereas fractional flow reserve, the... |
| - | HeartFlow | “Heartflow’s vision is to transform CAD from the leading cause of death into a disease that can be managed for life.” |
| - | HeartFlow Raises $215M for AI-Powered Cardiac Test | What You Should Know:
– HeartFlow, Inc., a provider of precision heart care raises $215M in Series F funding round led by Bain Capital Life Sciences with participation from new investor Janus Henderson Investors, and existing investors incl... |
| - | 5 cardiovascular disease medical device companies to watch | Estimates on the size of the U.S. market for treating cardiovascular disease vary, but few doubt the market is big and getting bigger.
Americans afflicted with cardiovascular diseases like cardiomyopathy, congestive heart failure, arrhythmi... |
